Deepinder Goyal Defends Temple Wearable Amid Pricing and Scientific Validity Concerns
Deepinder Goyal, founder of Temple and Zomato, has defended his Rs 85,000 Temple wearable device amid criticism over its pricing, scientific claims, and intended market. He clarified that Temple is a fitness AI device, not a medical tool, and is designed primarily for global markets, with India expected to account for less than 1% of sales. Medical professionals, including hepatologist Cyriac Abby Philips, have questioned the scientific validity of the device's brain blood flow monitoring claims. Goyal emphasized ongoing research and invited consumers to await peer-reviewed evidence before purchasing.
First-hand measurement across 15 sources
We measured how 15 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (45/100). Lens Score 40/100.
Outlets measured: news18, indianexpress, thehindu, moneycontrol, indianexpress, businessstandard, mint, mint, and 7 more. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (28–52/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 9 Nov, 05:48 am. Other outlets followed.